Subphenotypes of self-reported symptoms and outcomes in long COVID: a prospective cohort study with latent class analysis
Open Access
Abstract
Objective To characterise subphenotypes of self-reported symptoms and outcomes (SRSOs) in postacute sequelae of COVID-19 (PASC). Design Prospective, observational cohort study of subjects with PASC. Setting Academic tertiary centre from five clinical referral sources. Participants Adults with COVID-19 ≥20 days before enrolment and presence of any new self-reported symptoms following COVID-19. Exposures We collected data on clinical variables and SRSOs via structured telephone interviews and performed standardised assessments with validated clinical numerical scales to capture psychological symptoms, neurocognitive functioning and cardiopulmonary function. We collected saliva and stool samples for quantification of SARS-CoV-2 RNA via quantitative PCR. Outcomes measures Description of PASC SRSOs burden and duration, derivation of distinct PASC subphenotypes via latent class analysis (LCA) and relationship with viral load. Results We analysed baseline data for 214 individuals with a study visit at a median of 197.5 days after COVID-19 diagnosis. Participants reported ever having a median of 9/16 symptoms (IQR 6–11) after acute COVID-19, with muscle-aches, dyspnoea and headache being the most common. Fatigue, cognitive impairment and dyspnoea were experienced for a longer time. Participants had a lower burden of active symptoms (median 3 (1–6)) than those ever experienced (pConclusions We identified three distinct PASC subphenotypes. We highlight that although most symptoms progressively resolve, specific PASC subpopulations are impacted by either high burden of constitutional symptoms or persistent olfactory/gustatory dysfunction, requiring prospective identification and targeted preventive or therapeutic interventions.Keywords
All Related Versions
Funding Information
- Pfizer, Inc
This publication has 26 references indexed in Scilit:
- Development of a Definition of Postacute Sequelae of SARS-CoV-2 InfectionJAMA, 2023
- Risk Factors Associated With Post−COVID-19 ConditionJAMA Internal Medicine, 2023
- Prevalence and Characteristics Associated With Post–COVID-19 Condition Among Nonhospitalized Adolescents and Young AdultsJAMA Network Open, 2023
- Why we need a deeper understanding of the pathophysiology of long COVIDThe Lancet Infectious Diseases, 2023
- Association of Post–COVID-19 Condition Symptoms and Employment StatusJAMA Network Open, 2023
- The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysiseClinicalMedicine, 2022
- Prevalence and Correlates of Long COVID Symptoms Among US AdultsJAMA Network Open, 2022
- Neuroradiological Basis of COVID‐19 Olfactory Dysfunction: A Systematic Review and Meta‐AnalysisThe Laryngoscope, 2022
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- Validation of the Insomnia Severity Index as an outcome measure for insomnia researchSleep Medicine, 2001